Evotec stock falls as shares reach a new 52-week low

Published on 09/22/2026 at 11:04 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

Evotec stock closed at EUR 2.79 on September 21, 2026, after a 4.12 percent fall. First-half 2026 revenue fell nearly 20 percent and adjusted EBITDA turned negative.

Fotorealistisches Pharma-Labor mit Wissenschaftlern bei Wirkstoffscreening in moderner Biotech-Anlage — Fotorealistisches Pharma-Labor symbolisiert Wirkstoffforschung von Evotec SE, ISIN DE0005664809, moderner Biotech-Standort Hamburg, Illustration mit AI erstellt.

Evotec SE (ISIN DE0005664809) closed at EUR 2.79 on Xetra on September 21, 2026, down 4.12 percent from the previous close. The decline extended a difficult trading pattern as the shares reached a new 52-week low of EUR 2.73 on September 22, 2026.

Revenue falls in first half

The operating backdrop has weakened alongside the share price. According to Ad-hoc-news on September 21, 2026, Evotec reported first-half 2026 revenue nearly 20 percent below the prior-year period. Adjusted EBITDA also turned negative in the first half of 2026, compared with a positive result a year earlier.

Quarterly data cited by finanzen.ch on September 22, 2026, show revenue of EUR 143.48 million in the latest quarter, down 16.21 percent from EUR 171.24 million in the comparable prior-year quarter. The same report puts quarterly loss at EUR 0.26 per share.

Analyst view stays divided

According to MarketBeat on September 21, 2026, four analysts hold a consensus rating of Hold, with one Buy, two Hold and one Sell recommendation. The average price target is USD 3.00, while the published target range spans USD 2.00 to USD 4.00.

The comparison between the market data and the analyst range highlights the central tension. The Nasdaq-listed ADR last traded at USD 1.5550 on September 21, 2026, after touching USD 1.56 and following a prior close of USD 1.60, according to the MarketBeat market report. The US quotation is an additional venue and is not the reference price for the German issuer.

Stock remains near yearly low

Evotec's primary reference price was EUR 2.79 on Xetra at the September 21, 2026 close. The shares then reached EUR 2.73 on September 22, 2026, leaving the stock close to its 52-week low of EUR 2.73 and far below the 52-week high of EUR 7.30 recorded on October 27, 2025.